Automated tracking of nanoparticle-labeled melanoma cells improves the predictive power of a brain metastasis model

This study describes a model that can improve upon the predictive elements derived from preclinical studies of brain metastasis, perhaps ultimately helping reduce the number of clinical trials that fail to show patient benefit.